imetelstat
geron corporation
['mds']
#asco2023 | moffitt's dr. rami komrokjii discusses the results of a phase 3 clinical trial of imetlestat, a telomerase inhibitor used for treating for both mds and myelofibrosis. #moffittasco23 
Moffitt Cancer Center is a global leader in patient care, research and education with a mission to contribute to the prevention and cure of cancer.